Drug interactions
Metformin-repaglinide + Semaglutide
Severity: Moderate
Metformin-repaglinide and Semaglutide: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Semaglutide enhances glucose-dependent insulin secretion and, combined with repaglinide, an insulin secretagogue, can increase the risk of hypoglycemia. Semaglutide also slows gastric emptying and reduces appetite, which may further raise this risk.
What this interaction means in plain words
Metformin-repaglinide and Semaglutide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Metformin-repaglinide belongs to Endocrine; Semaglutide belongs to Endocrine.
Why it happens
Additive pharmacodynamic stimulation of insulin secretion and reduced food intake.
What to do
Monitor blood glucose when semaglutide is started or titrated, and reduce the repaglinide dose if hypoglycemia occurs. Advise patients about hypoglycemia symptoms.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Metformin-repaglinide and Semaglutide, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-repaglinide
Other interactions of Semaglutide
Frequently asked questions
Can I take Metformin-repaglinide with Semaglutide?
MediHelp rates the interaction as moderate. Metformin-repaglinide and Semaglutide can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Semaglutide enhances glucose-dependent insulin secretion and, combined with repaglinide, an insulin secretagogue, can increase the risk of hypoglycemia. Semaglutide also slows gastric emptying and reduces appetite, which may further raise this risk.
How serious is the interaction between Metformin-repaglinide and Semaglutide?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose when semaglutide is started or titrated, and reduce the repaglinide dose if hypoglycemia occurs. Advise patients about hypoglycemia symptoms.
What other medicines interact with Metformin-repaglinide?
MediHelp also lists interactions of Metformin-repaglinide with, for example, Gemfibrozil, Apalutamide, Clarithromycin. The full list is on the Metformin-repaglinide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
